Crispr Therapeutics (NASDAQ:CRSP) Research Coverage Started … – StockNewsTimes
|
Crispr Therapeutics (NASDAQ:CRSP) Research Coverage Started …
StockNewsTimes Oppenheimer began coverage on shares of Crispr Therapeutics (NASDAQ:CRSP) in a report issued on Thursday, December 7th. The firm issued a hold rating on the stock. A number of other analysts also recently issued reports on CRSP. Chardan Capital … A Look at 2 Trending Stocks: CRISPR Therapeutics AG (CRSP … Analyst Research and Recommendations: CRISPR Therapeutics AG (CRSP), Drive Shack Inc. (DS) Crispr Therapeutics AG (CRSP) Insider Tyler Dylan-Hyde Sells … |
